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1. Introduction 
Since the earliest metacarpophalangeal (MCP) arthroplasties in the 1950s, numerous 
resurfacing and excisional arthroplasties, and a greater choice of surgical tools and 
techniques to implant the prostheses have become available. Of the excisional arthroplasties, 
one-piece and two-piece hinge designs, constrained by screws or unconstrained, cemented 
and non-cemented, have been designed (1) Surgeons now perform these procedures as day 
surgery, and leave as much original bone as possible in the likelihood of replacing the 
prosthesis as the patient ages.  
At the time of surgery, synovectomy and soft-tissue balancing procedures are often 
performed to increase lateral joint stability or enhance the biomechanical advantage of the 
tendons around the operated joint. These procedures may necessitate post-operative 
immobilisation, specific joint positioning and strict motion protocols to achieve the best soft 
tissue range of motion and stability around the prosthesis (2-6). 
The efficacy of postoperative therapy regimens also requires research, as they affect patient 
outcome, and are time-consuming and expensive. The aim of this review is to determine 
which postoperative regimen are most effective in achieving freedom from pain and 
function, and if any particular regimen is best suited to a specific prosthesis or soft-tissue 
balancing procedure at the time of surgery. 
2. Method 
For inclusion in this review, studies had to evaluate the efficacy of a post-arthroplasty 
regimen for patients who had metacarpophalangeal or joint arthroplasty. Preferred study 
designs were metanalyses, systematic reviews, and randomised controlled trials, but all 
published literature except expert opinion was accepted.  Patients may have received any 
type of implant and soft-tissue procedure, due to rheumatoid arthritis, osteoarthritis or 
trauma. 
Electronic databases searched were the Cochrane Musculoskeletal Disease Group Register, 
The Cochrane Library of Systematic review, Google Scholar, and Scopus. Manual searches 
included of the Journal of Hand Therapy, Hand Therapy and the Journal of Arthroplasty. 
Search terms in all combinations included ‘joint replacement, hand, wrist 
metacarpophalangeal, arthroplasty, rehabilitation, post-operative, occupational therapy, 
physical therapy’. The search included papers from 1990 onward, aiming to find research 
about currently used prostheses and not prostheses of older designs and materials. 
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Studies were appraised as described by the Cochrane Collaboration (7) for sources of 
methodological bias that could decrease the internal validity of a study. The types of 
methodological bias were in patient selection, equality of treatment, attrition of patients, and 
detection of all relevant outcomes. If the study could not be fully appraised from the 
publication, information was sought by writing to the authors.  
3. Results 
Sixteen studies described post-operative therapy for MCP joint replacement in enough detail 
to understand the treatment schedule. Four hundred and twenty-seven patients in these 
studies had rheumatoid arthritis, 19 had osteoarthritis and one had psoriatic arthritis. There 
were four randomised trials (one about post-operative therapy), three prospective cohort 
studies, three prospective case series (two about post-operative therapy), one case study 
about post-operative therapy, and the remaining were retrospective case series. Missing 
data was obtained from two authors, to assist in reviewing the rigour of the studies, but 
many authors could not be contacted. 
The randomised controlled trial study found to specifically compare post-operative 
regimes for metacarpophalangeal arthroplasty (8) randomised patients into 
postoperative therapy groups that both included dynamic splinting, but the treatment 
group also included continuous passive motion. These researchers found no difference 
between treatment groups. Thomsen, Boeckstyns and Leth-Espensen(2003) (9) and 
retrospectively reviewed consectutive patients who had either dynamic MCP extension 
splinting, or had static splinting that was removed for exercises post-operatively. They 
found that residual extension lag was significantly less (p = 0.002) in the dynamically-
splinted  group, concluding that postoperative dynamic splinting was useful. Groth, 
Watkins and Paynter, (1996)(10) retrospectively compared patients who had dynamic 
flexion with those who had dynamic extension splinting, and found that those who had 
post-operative dynamic flexion splinting had greater post-operative MCP flexion. Burr, 
Pratt and Smith (2002)(11), Burr and Pratt (1999)(12) focussed their research on post-
operative therapy, but neither study had a comparison treatment group. No further 
studies compared post-operative treatment regimes, therefore the results of the 
remaining studies can only be appreciated as a combination of surgery, implant and 
post-operative therapy. 
One outcome common to nearly all postoperative patients in every study was the relief of 
pain once the diseased joint had been removed by surgery. Negative outcomes such as 
wound infection, implant loosening and migration were reported, in small proportions. 
Compliance with splinting and therapy was not discussed. Sixteen studies described the 
outcome of different implants and postoperative therapy regimes for MCP arthroplasty. 
Features common to many regimens (Table 1) were postoperative avoidance of any hand 
activity for the first three to six weeks and long-term avoidance of ulnar forces on the 
fingers. Nearly all regimens began between the second and seventh postoperative day. 
Regimens could be divided into two main categories with regard to splinting and exercise. 
Static splint regimens involved removal of the splint for active MCP range of motion 
exercises, and dynamic splint regimens involved active-assisted MCP extension and active 
MCP flexion exercises within the splint.  
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Sixteen studies described the outcome of different implants and postoperative therapy 
regimes for MCP arthroplasty. Two of these studies compared the efficacy of one regimen 
over another, one of these being prospective. Sambandam, Gul and Priyanka (2007)(25) state 
that ‘most studies undermined the importance of this aspect (post-operative treatment) of 
the procedure’ with regards to first carpometacarpal joint arthroplasty, but their claim could 
be expanded to arthroplasty of other joints of the hand. Post-operative protocols for 
splinting, activity and exercises are not always well-described, so although there were 
numerous studies about MCP arthroplasty, they are not included in this review.  
Hand therapy for other conditions such as flexor tendon repair also offers multiple 
postoperative regimens. For example, healing tendons of the hand usually receive motion, 
but it may be passive, active, or a combination of all of these. The rationale for the various 
exercise regimens is based on biological healing of the tendon and the strength of the 
surgical repair, thus its ability to withstand stress without rupturing or gap formation 
(26,27). These patients usually have normal anatomy preoperatively, leaving few patient 
variables. Postoperative therapy regimens for MCP arthroplasty are also based on 
principles of healing and scar formation, but are not prescribed according to the patient's 
preoperative hand impairment, the type of implant used, or soft tissue balancing 
procedures performed. For example, patients having undergone extensor tendon 
rebalancing and recentralization may benefit from avoidance of passive flexion or 
avoidance of the extremes of flexion, much like a postoperative extensor tendon repair 
regime. The literature suggests that postoperative therapy for MCP arthroplasty has not 
been prescribed in this manner; rather, standard protocols have been designed and 
applied to consecutive patients. 
To compare the efficacy of a new protocol, many patients would be required for allocation 
to various postoperative therapy groups. Their outcomes would have to be analyzed 
according to what protocol they received with the implant, surgery, and preoperative status 
as variables. The first difficulty in forming control or comparison groups lies in the 
infrequency of this procedure; for example Ring et al.(8) took three years to include 25 
hands in their study. 
The most common source of bias in the studies was selection bias, which occurs when 
patients are chosen for treatment or control groups as a result of characteristics that are 
expected to affect their outcome. Randomization is designed to control the confounding 
effects of differences between subjects at baseline, and the randomized trial is recommended 
as the best method of determining treatment efficacy. Here lies the second difficulty in 
forming control or comparison groups. Patients undergo MCP arthroplasty at all stages of 
their disease, evidenced by the wide range of motion deficits between the studies of Burr 
and Pratt, in which the case study patient had nearly normal preoperative MCP motion, and 
Burr et al., in which some patients had only 25° of MCP flexion, Measures of pain also 
varied widely in the latter study, ranging from "zero" to "eight out of ten." These baseline 
measurements demonstrate the difficulty in obtaining a homogeneous, comparable group of 
patients with rheumatoid arthritis. 
The other three sources of bias described by the Cochrane Collaboration(7) were present in 
the reviewed studies. Performance bias occurs when patients receive a variation in duration, 
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quality, or quantity of the treatment being studied, which was suspected in the continuous 
passive motion (CPM) study by Ring et al. Ring et al. describe the application of CPM in 
detail, except passive forces are described as "low" and treatment quantity is described as "as 
tolerated." As a result, the reader remains unsure of what amount of passive force is 
ineffective, as well as what quantity of treatment per day is ineffective. 
Detection bias is determined if the timing of assessment, the outcome assessment used, or 
knowledge of the assessor of the patient's previous state could miss any relevant aspect of 
the outcome. This may have occurred in the study by Groth et al.,(10) in which some 
preoperative data were unavailable and patients were assessed at different postoperative 
time frames. Detection and comparison of outcomes between studies are only possible 
when the same outcome measures are used in a standardized manner. The researchers in 
this review all measured range of motion, but at different time frames (Table 1). Those 
who measured pain, cosmesis, and function applied different assessments at different 
time frames. The challenge of outcome measurement in rheumatology has led to the 
formation of focus groups such as OMERACT (Outcome Measures in Rheumatoid 
Arthritis Clinical Trials), who have made recommendations for outcome measures to be 
used in drug trials. OMERACT recommendations are not fully relevant to hand therapy 
research; however, the process of forming a focus group, and the development of 
assessment guidelines that allow comparison between homogeneous patients, is possible 
(28). 
Attrition bias is determined if the loss of patients in the study is significant or varies 
between the treatment and control groups. This is common in long-term studies involving 
patients with rheumatoid arthritis, and was experienced by Groth et al.,(10) who were 
unable to obtain long-term follow-up of the patient group who received their extension 
protocol. Long-term follow-up is an issue with rheumatoid populations. These patients 
undergo numerous surgical and drug interventions, while their disease progresses and 
fluctuates, making the long-term effects of the MCP surgery and therapy difficult to 
define. Once more, large numbers of patients in each treatment group would be required 
to decrease the effects of attrition bias and to dilute the effects of subsequent 
interventions. 
The difficulties of past studies guide the planning of future studies. Although the issues of 
low patient numbers, variable preoperative status, additional surgical and drug 
interventions, and chronic disease cannot be altered, study designs can. Large 
randomized trials may not be possible; however, samples of patients, paired according to 
preoperative status, may be allocated to different treatment protocols. Standardized 
measurement of pain, cosmesis, impairment, disability, and impact on the patient, made 
at similar postoperative time frames, would further assist in determining treatment 
efficacy.  
5. Conclusion 
This review suggests that all regimens contribute toward an increase in MCP motion and 
an increase in hand function, but despite the efforts of patients and clinicians, hand 
therapists remain unaware of the most effective postoperative protocol for MCP 
arthroplasty or the suitability of each regimen for specific implants and soft-tissue 
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procedures. Difficulties in researching this topic include low patient numbers, highly 
variable preoperative status, lack of guidelines for outcome measures and time frames, 
and the effects of subsequent interventions received by the patient. The nature and size of 
the population with rheumatoid arthritis and MCP arthroplasty do not readily fit the 
randomized, controlled trial design. Paired sample designs are suggested, as well as the 
formation of standard outcome measures, for better comparison of results between 
patients. 
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